Discovery & Development

Jan Cools of the VIB Center for Cancer Biology discusses his experience with Mission Bio’s new DNA sequencing platform.

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Biotech companies need good patient samples, but hospitals are not always obliging...

Researchers at Trinity College Dublin explain how they are reaching into the natural environment to source new bioactives.

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

A wall of data stands between humankind and a revolution in our understanding of the body and its systems. AI can tear it down.

In this video interview, Mike Rea explains why each drug needs its own launch strategy.

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.